Metabolomics Reagents Market
Metabolomics Reagents Market Size and Growth
The Metabolomics Reagents market is experiencing robust growth, driven by advancements in analytical technologies and increasing research funding. The market size is projected to reach approximately $1.5 billion by 2030. Key trends include rising demand for personalized medicine and the integration of metabolomics in clinical diagnostics and drug discovery applications.
Companies Covered
(Covid 19 Impact Covered)
◍ BioVision
◍ Merck
◍ Thermo Fisher Scientific
◍ BD
◍ Abbott
◍ Kerafast
◍ Beijing Strong Biotechnologies
◍ Pointe Scientific
◍ Luxcel Biosciences
◍ Randox Laboratories Limited
◍ Beijing Leadman Biochemistry
◍ Shenzhen Bioeasy Biotechnology
◍ Shenzhen Lvshiyuan Biotechnology
◍ BioSino
◍ NITTO BOSEKI
The metabolomics reagents market features key players such as BioVision, Merck, and Thermo Fisher Scientific, which supply tools for metabolic analysis. These companies drive market growth through innovation in product offerings and strategic partnerships. Some reported sales figures include Merck’s revenue of $23 billion and Thermo Fisher’s $40 billion.
Market Segmentation
By Application
Diabetes
Obesity
Others
By Product
◍ Glycometabolism
Amino Acid Metabolism
Fatty Acid/Cholesterol Metabolism
Others
Request Sample Report
Market Growth
Request Sample Report
$ X Billion USD
